Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ketorolac in Polytrauma
NCT03671746Phase 1Completed
- Start
- Feb 2019
- Primary completion
- Jun 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, triple-blind trial of ketorolac in polytrauma (2 arms). Primary endpoint: Length of Hospital Stay up to 30 days. Started Feb 2019; status: completed.
02
Drugs
ketorolac
03
Conditions
polytrauma
Beyond the preview
Go deeper on NCT03671746.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03671746.